Financial Mail and Business Day

Healthcare’s future not in a state/private binary choice

By ANDREW SCHWULST -Schwulst is CEO of Medscheme, a health administration, risk management and managed care company in the AfroCentric Group.

SA’s healthcare landscape has undergone transformation since the dawn of democracy, shaped by reforms designed to ensure equitable access and improve population health outcomes. Among these was the introduction of the Medical Schemes Act of 1998, which laid the foundation for a regulated, fairer private healthcare market. It introduced crucial protections such as community rating, open enrolment and prescribed minimum benefits.

Yet despite three decades of progress, many structural and legacy challenges persist. The public sector, burdened by historical underfunding and inequality, continues to serve the majority of the population — 84% of South Africans — often with limited resources. The government has achieved notable strides in building a more equitable system: expanding maternal and child health programmes, improving access to chronic medication and rolling out successful vaccination and HIV/Aids treatment campaigns.

Still, the gap between the public and private sectors remains stark, with only 16% of South Africans accessing private medical schemes. This discrepancy underscores the opportunity for the private sector to extend its role, particularly in the context of SA’s vision for universal health coverage, which is not only a developmental imperative but a constitutional right.

It is neither practical nor productive to frame healthcare reform as a binary choice between public and private systems. Rather, the future lies in a well-structured partnership model in which medical schemes, administrators and the state collaborate to create a high-performing, integrated national health system. The private sector brings decades of institutional knowledge in managing risk, financing care and deploying clinical innovations that can meaningfully support state efforts.

One is the evolution of low-cost benefit options (LCBOs), which bridge the affordability gap for the working uninsured. These products cater to individuals who fall outside the income bracket of traditional medical aid but seek alternatives to strained public services. If enabled through supportive regulation, LCBOs could extend quality healthcare to millions, advancing the national agenda of inclusion.

Public-private partnerships are already proving their value. Collaborations between medical schemes and public hospitals have resulted in centres of excellence, where expertise, infrastructure and outcomes converge to deliver better care. These initiatives exemplify how private sector agility complement public sector reach, improving overall system efficiency.

During global disruptions like the Covid-19 pandemic, medical schemes have demonstrated operational resilience, maintaining benefit raises while limiting contribution increases. Several schemes passed cost savings back to members during low-claim periods, reinforcing their role as responsible corporate citizens. This level of stability and stewardship is critical in a volatile economic climate.

But even in the private system there are pressing challenges. The traditional fee-for-service model continues to incentivise volume over value, driving up costs without commensurate improvements in patient outcomes. For those with complex and chronic conditions the system can be fragmented and impersonal.

The path forward lies in adopting a value-based care model. This global shift prioritises clinical outcomes and patient satisfaction over transactional billing. Innovation will be pivotal.

Technology is revolutionising healthcare — through AI-driven diagnostics, remote patient monitoring and digital health platforms that enable better adherence and early intervention.

To build a sustainable and inclusive healthcare system the sector must also invest in data interoperability and integrated platforms that support co-ordinated care across providers, institutions and geographies.

Looking ahead, medical schemes should not be viewed solely as vehicles for the privileged few. Their expertise, infrastructure and innovation capacity make them essential building blocks in universal health coverage. By fostering strategic alignment between the private and public sectors we can accelerate access to quality care — without sacrificing financial sustainability.

OPINION

en-za

2025-05-05T07:00:00.0000000Z

2025-05-05T07:00:00.0000000Z

https://bd.pressreader.com/article/281715505493702

Arena Holdings PTY